Despite impressive medical strides, cancer remains a leading killer and overwhelming burden to healthcare systems, causing well over a half million fatalities per year with a projected cost of $174 billion by 2020, according to the National Cancer Institute. 922 more words
Tags » Antibody
After a series of late-stage failures, Sanofi has returned the rights to the cancer compound MM-121 to Merrimack Pharmaceuticals.
MM-121, a monoclonal antibody designed to block ErbB3 activation in patients with heregulin-positive tumours, has been tested in Phase II trials in partnership with the French giant in ovarian, breast and lung cancer. 772 more words
Looking for a way to keep your immunology or virology lessons fresh? Consider teaching the lesson from a biomedical diagnostic point of view! Here, we describe how the West Nile Virus can be used to teach the Enzyme Linked Immunosorbent Assay (or ELISA). 622 more words